Navigation Links
AbbVie to Host Second-Quarter Earnings Conference Call
Date:7/23/2014

ts to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing. Disclosures are therefore required in the shares of AbbVie and Shire plc.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3. Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).
Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Takeover Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

No Offer or Solicitation
This release is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, e
'/>"/>

SOURCE AbbVie
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AbbVie to Host Fourth-Quarter and Full-Year 2013 Earnings Conference Call
2. AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
3. AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy
4. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
5. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
6. AbbVie Reports Third-Quarter 2013 Financial Results
7. AbbVie Named a Science Top Employer
8. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
9. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
10. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
11. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. ... inoperable solid tumor cancers, announced today that CEO Linda ... Phacilitate Immunotherapy Forum in Washington D.C. ... on January 26 at 10:30 a.m. EST at the Grand ...
(Date:1/23/2015)... Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, is ... pain reliever Myoflex, Ducere Pharma has announced. "Pete,s ... excited to have him on board with Myoflex," said Ducere ... a legendary player who is known across all generations. The ...
(Date:1/23/2015)... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange ... shareholders detailing why a "YES" vote to increase the number ... As we reflect upon the 2014 fiscal year that ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... New Zealand, Aug. 24 Rex Bionics Ltd., the ... walk, announced formation of an International Advisory Board that ... Williams .  Also named to the new board were ... of Virginia, Charlottesville, Va., and Frank Gardner, the BBC,s ...
... Bulletin Board: SNDZ ), announced today that it ... key brokers and funds.  The purpose of these meetings will ... facilitate funding for Sunridge to execute its business plan for ... this project," states G. Richard Smith, CEO of Sunridge.  "We ...
Cached Medicine Technology:Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board 2
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
(Date:1/22/2015)... is a famous dress online store for wedding dresses and ... collection of wedding dresses , and launches a site-wide women’s ... dress on your big day; the wedding gown is the ... to find the most suitable wedding dress. Now, we are ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... minority patients generally receive a lower quality of ... these disparities be reduced? A supplement to the ... Review, published by SAGE, thoroughly explores the effectiveness ... , The supplement features research from the Finding ...
... Inc. (OTC BB:,ALRX), a specialty pharmaceutical company dedicated ... inflammatory and infectious disease,today announced the retirement of ... unanimous resolution of the Board of Directors, certain,unsecured ... officers and third,party investors, including earned and unpaid ...
... 28 Cardiac Science,(Nasdaq: CSCX ), a ... has been named to Deloitte,s prestigious,Technology Fast 50 ... 50,fastest growing technology, media, telecommunications, and life sciences,companies ... LLP, one of the nation,s,leading professional services organizations. ...
... Small Bone Innovations,Inc. (SBi), a single-source provider of ... joint orthopedic market sector, announced today the,launch of ... further,augment its Elbow Management System, the company also ... proximal radius,fractures. The rHead Lateral Implant is ...
... that helps them appreciate another,s discomfort shuts down, study finds ... to switch off the part of their brain that helps ... turn on a brain area that controls emotions, according a ... have to inflict pain on patients while treating them, doctors ...
... Euro 39 Million - Aesthetic Therapies and Ambulant Urology Laser ... ... September 28 , http://www.biolitec.com - biolitec AG, Jena listed in ... increase the,revenues during the fiscal year ending June, 30 2007 by ...
Cached Medicine News:Health News:Cardiac Science Named to Deloitte's Technology Fast 50 for Washington State 2Health News:Cardiac Science Named to Deloitte's Technology Fast 50 for Washington State 3Health News:Cardiac Science Named to Deloitte's Technology Fast 50 for Washington State 4Health News:SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System 2Health News:SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System 3Health News:SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System 4Health News:Brain 'Switch' Helps Doctors Deal With Patients' Pain 2Health News:biolitec AG - Record Profit in FY 2006/07 With a Growth of 191% to Euro 6,7 Million 2
BD Beaver DeBakey blade, 5 mm cutting width, sterile....
RM-1970 Mucotome ergonomic design with E-Type coupling, designed for mucosal repair surgery....
RM-1900 Dermatome developed for reconstructive plastic surgery with E-Type coupling. Dermatome with 50 mm cutting width....
... Model C Dermatome - reaching a new evolutionary ... forward to operate in the pulse mode, or ... the entire instrument and hose assembly is autoclavable ... in 2-, 3-, or 4-inch widths. Simply select ...
Medicine Products: